The real opportunity of AI lies not just in the tools, but in an educator workforce prepared to wield them. When done right, this investment in human infrastructure ensures AI accelerates learning outcomes for all students, closing the “digital design divide.”
Good information sources, like collections, must be available and maintained if companies are going to successfully implement the vision of AI for science expressed by their marketing and executives.
Nestled in the cuts and investments of interest to the S&T community is a more complex story of how the administration is approaching the practice of science diplomacy.
By structuring licensing-and-talent deals that replicate mergers while avoiding antitrust scrutiny, dominant technology firms are reshaping AI labor markets, venture financing, and the future of U.S. innovation.
Each publication developed under this initiative focuses on a distinct aspect of health and innovation, from artificial intelligence in healthcare, to rethinking national health frameworks, to advancing heat-health resilience.
The federal government is closely examining how it plays a role in supporting students, families, and educators – reimagining its approach to funding education R&D, pausing much of its investment in education outside the U.S., and completely reconceiving the structure of agencies responsible for education.
We’re seeking proposals that identify specific fairness harms associated with AI and propose actionable policy solutions at the federal, state, and local levels.
AI safety is a rapidly evolving field that draws attention from a diverse range of policymakers across the political spectrum, including those in Congress, federal agencies, and state and local governments.
We engage with the public, academia, and the private sector to foster a broader understanding of AI and emerging technology policy issues.
The U.S. bioeconomy is growing rapidly, innovation is needed to sustain and maintain this growth. Shaping policy to consider workforce development, advanced agriculture, bioindustrial and biotech sectors will be imperative to keep the needle moving forward.
We aim to catalyze a more nimble science funding ecosystem, capable of keeping up with and facilitating new innovations to improve the lives of people around the world.
